S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   416.75 (-1.57%)
AAPL   164.96 (-1.25%)
MSFT   399.36 (-1.21%)
META   483.88 (-3.57%)
GOOGL   153.97 (-1.31%)
AMZN   174.95 (-2.38%)
TSLA   148.99 (-0.63%)
NVDA   801.70 (-5.32%)
AMD   149.10 (-3.86%)
NIO   3.83 (-4.25%)
BABA   68.89 (+0.01%)
T   16.35 (+0.12%)
F   12.10 (+0.33%)
MU   107.04 (-4.37%)
GE   149.12 (-2.50%)
CGC   8.09 (+3.32%)
DIS   112.09 (-0.30%)
AMC   3.23 (+10.62%)
PFE   25.79 (+1.58%)
PYPL   62.18 (+0.13%)
XOM   119.90 (+1.16%)
S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   416.75 (-1.57%)
AAPL   164.96 (-1.25%)
MSFT   399.36 (-1.21%)
META   483.88 (-3.57%)
GOOGL   153.97 (-1.31%)
AMZN   174.95 (-2.38%)
TSLA   148.99 (-0.63%)
NVDA   801.70 (-5.32%)
AMD   149.10 (-3.86%)
NIO   3.83 (-4.25%)
BABA   68.89 (+0.01%)
T   16.35 (+0.12%)
F   12.10 (+0.33%)
MU   107.04 (-4.37%)
GE   149.12 (-2.50%)
CGC   8.09 (+3.32%)
DIS   112.09 (-0.30%)
AMC   3.23 (+10.62%)
PFE   25.79 (+1.58%)
PYPL   62.18 (+0.13%)
XOM   119.90 (+1.16%)
S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   416.75 (-1.57%)
AAPL   164.96 (-1.25%)
MSFT   399.36 (-1.21%)
META   483.88 (-3.57%)
GOOGL   153.97 (-1.31%)
AMZN   174.95 (-2.38%)
TSLA   148.99 (-0.63%)
NVDA   801.70 (-5.32%)
AMD   149.10 (-3.86%)
NIO   3.83 (-4.25%)
BABA   68.89 (+0.01%)
T   16.35 (+0.12%)
F   12.10 (+0.33%)
MU   107.04 (-4.37%)
GE   149.12 (-2.50%)
CGC   8.09 (+3.32%)
DIS   112.09 (-0.30%)
AMC   3.23 (+10.62%)
PFE   25.79 (+1.58%)
PYPL   62.18 (+0.13%)
XOM   119.90 (+1.16%)
S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   416.75 (-1.57%)
AAPL   164.96 (-1.25%)
MSFT   399.36 (-1.21%)
META   483.88 (-3.57%)
GOOGL   153.97 (-1.31%)
AMZN   174.95 (-2.38%)
TSLA   148.99 (-0.63%)
NVDA   801.70 (-5.32%)
AMD   149.10 (-3.86%)
NIO   3.83 (-4.25%)
BABA   68.89 (+0.01%)
T   16.35 (+0.12%)
F   12.10 (+0.33%)
MU   107.04 (-4.37%)
GE   149.12 (-2.50%)
CGC   8.09 (+3.32%)
DIS   112.09 (-0.30%)
AMC   3.23 (+10.62%)
PFE   25.79 (+1.58%)
PYPL   62.18 (+0.13%)
XOM   119.90 (+1.16%)

Precigen (PGEN) News Today

$1.31
-0.01 (-0.76%)
(As of 01:39 PM ET)
SourceHeadline
prnewswire.com logoPrecigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th
prnewswire.com - March 28 at 4:05 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Precigen (PGEN), Cronos Group (CRON) and Marinus (MRNS)
markets.businessinsider.com - March 26 at 7:58 PM
msn.com logoJ.P. Morgan cuts Precigen to underweight, cites burn rate
msn.com - March 22 at 6:03 PM
marketbeat.com logoPrecigen (NASDAQ:PGEN) Downgraded by JPMorgan Chase & Co. to Underweight
marketbeat.com - March 22 at 8:17 AM
marketbeat.com logoPrecigen, Inc. (NASDAQ:PGEN) to Post Q1 2024 Earnings of ($0.09) Per Share, HC Wainwright Forecasts
marketbeat.com - March 22 at 7:34 AM
bizjournals.com logoGermantown biotech expands manufacturing capacity, headcount ahead of potential product launch
bizjournals.com - March 21 at 6:00 PM
markets.businessinsider.com logoBuy Rating Affirmed on Precigen Amid Promising PRGN-2012 Clinical Progress and Financial Stability
markets.businessinsider.com - March 20 at 5:19 PM
finance.yahoo.com logoPrecigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 20 at 4:34 PM
marketbeat.com logoPrecigen's (PGEN) "Market Outperform" Rating Reaffirmed at JMP Securities
marketbeat.com - March 20 at 10:39 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Precigen (PGEN) and Taysha Gene Therapies (TSHA)
markets.businessinsider.com - March 20 at 5:18 AM
seekingalpha.com logoPrecigen, Inc. (PGEN) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 19 at 10:05 PM
investorplace.com logoPGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q4 2023
investorplace.com - March 19 at 10:01 PM
finance.yahoo.com logoPrecigen Inc (PGEN) Reports Full Year 2023 Financial Results
finance.yahoo.com - March 19 at 5:55 PM
benzinga.com logoRecap: Precigen Q4 Earnings
benzinga.com - March 19 at 5:22 PM
finance.yahoo.com logoPrecigen Reports Full Year 2023 Financial Results and Business Updates
finance.yahoo.com - March 19 at 5:05 PM
msn.com logoUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat
msn.com - March 19 at 7:54 AM
benzinga.com logoPreview: Precigen's Earnings
benzinga.com - March 18 at 11:01 AM
msn.com logoAnika Therapeutics to reduce workforce by 9%
msn.com - March 14 at 4:42 AM
finance.yahoo.com logoPrecigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis
finance.yahoo.com - March 12 at 5:56 PM
finance.yahoo.com logoPrecigen, Inc.'s (NASDAQ:PGEN) top owners are private equity firms with 38% stake, while 30% is held by institutions
finance.yahoo.com - March 8 at 7:39 AM
prnewswire.com logoPrecigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th
prnewswire.com - March 5 at 4:05 PM
finance.yahoo.com logoPrecigen, Inc. (NASDAQ:PGEN): When Will It Breakeven?
finance.yahoo.com - February 20 at 2:57 PM
finance.yahoo.com logoPGEN Mar 2024 1.500 call
finance.yahoo.com - February 15 at 7:32 PM
finance.yahoo.com logoPGEN Jul 2024 1.500 call
finance.yahoo.com - February 15 at 2:31 PM
finance.yahoo.com logoPGEN Jul 2024 2.500 put
finance.yahoo.com - February 15 at 9:31 AM
finance.yahoo.com logoPGEN Jul 2024 0.500 call
finance.yahoo.com - February 15 at 9:31 AM
msn.com logoPrecigen Finalizes Executive Severance Agreements
msn.com - February 9 at 8:53 AM
finance.yahoo.com logoPrecigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
finance.yahoo.com - February 6 at 5:45 PM
finance.yahoo.com logoInsider Stock Buying Reaches US$1.72m On Precigen
finance.yahoo.com - February 4 at 10:04 AM
finance.yahoo.com logoWe're Keeping An Eye On Precigen's (NASDAQ:PGEN) Cash Burn Rate
finance.yahoo.com - January 18 at 8:19 AM
msn.com logoPrecigen gets EU orphan drug status for respiratory tract drug
msn.com - January 16 at 12:18 PM
finance.yahoo.com logoPrecigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission
finance.yahoo.com - January 16 at 8:33 AM
marketbeat.com logoIridian Asset Management LLC CT Trims Holdings in Precigen, Inc. (NASDAQ:PGEN)
marketbeat.com - January 12 at 1:58 PM
markets.businessinsider.com logoBuy Rating on Precigen: Anticipated BLA Submission and Diverse Pipeline Drive Positive Outlook
markets.businessinsider.com - January 10 at 8:45 AM
finance.yahoo.com logoPrecigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 8 at 8:58 AM
nasdaq.com logoTuesday 1/2 Insider Buying Report: PGEN, TURN
nasdaq.com - January 4 at 6:23 PM
uk.finance.yahoo.com logoDirector Jeffrey Kindler Sells 96,686 Shares of Precigen Inc
uk.finance.yahoo.com - December 31 at 7:13 AM
marketbeat.com logoPrecigen, Inc. (NASDAQ:PGEN) Director Randal J. Kirk Acquires 96,686 Shares
marketbeat.com - December 29 at 9:28 PM
msn.com logoPrecigen files for $300M mixed shelf
msn.com - December 29 at 7:58 PM
finance.yahoo.com logoEven after rising 15% this past week, Precigen (NASDAQ:PGEN) shareholders are still down 86% over the past three years
finance.yahoo.com - December 27 at 9:37 AM
finance.yahoo.com logoPrecigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 18 at 6:55 PM
finance.yahoo.com logoPrecigen to Participate in the JMP Securities Hematology and Oncology Summit
finance.yahoo.com - November 29 at 4:56 PM
morningstar.com logoPrecigen Inc PGEN
morningstar.com - November 22 at 8:18 PM
markets.businessinsider.com logoPromising Pipeline Progress and Strong Financial Standing Justify Buy Rating for Precigen
markets.businessinsider.com - November 11 at 7:52 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Precigen (PGEN)
markets.businessinsider.com - November 10 at 1:35 PM
msn.com logoPrecigen GAAP EPS of -$0.08 in-line, revenue of $1.38M misses by $0.6M
msn.com - November 9 at 6:47 PM
finance.yahoo.com logoPrecigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs
finance.yahoo.com - November 9 at 6:03 PM
finance.yahoo.com logoPrecigen to Participate in the Stifel 2023 Healthcare Conference
finance.yahoo.com - November 7 at 5:10 PM
uk.finance.yahoo.com logoPrecigen, Inc. (PGEN)
uk.finance.yahoo.com - October 21 at 1:30 PM
finance.yahoo.com logoWhile institutions own 26% of Precigen, Inc. (NASDAQ:PGEN), private equity firms are its largest shareholders with 37% ownership
finance.yahoo.com - September 25 at 2:35 PM
Get Precigen News Delivered to You Automatically

Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter.

Did you know you can now trade Bitcoin in your regular brokerage account? (Ad)

You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history! That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords… Heck, you don’t even need a crypto wallet!

>> Tap here to sign up and join them for the imminent workshop

PGEN Media Mentions By Week

PGEN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PGEN
News Sentiment

0.00

0.52

Average
Medical
News Sentiment

PGEN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PGEN Articles
This Week

0

2

PGEN Articles
Average Week

Get Precigen News Delivered to You Automatically

Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PGEN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners